Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sympathetic Dysfunction and Muscle Spindle Activity in Fibromyalgia
NCT05704374Unknown
- Sponsor
- Istanbul Physical Medicine and Rehabilitation Training and Research Hospital
- Start
- Nov 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pregabalin in fibromyalgia syndrome (FMS) (2 arms), sponsored by Istanbul Physical Medicine and Rehabilitation Training and Research Hospital. Primary endpoints: Change from baseline in T-reflex amplitude after intervention and Change from baseline in H-reflex amplitude after intervention. Status: unknown.
02
Drugs
pregabalin
03
Conditions
fibromyalgia syndrome (FMS)
Beyond the preview
Go deeper on NCT05704374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05704374.